Please login to the form below

Not currently logged in
Email:
Password:

M3 Europe appoints Helen Parfitt and Grant Irwin

Healthcare technology company boosts its senior team

M3 Europe Helen ParfittM3 Europe has boosted its senior team, appointing Helen Parfitt as commercial director and Grant Irwin as VP and head of sales.

Parfitt joins the UK-based healthcare technology company from IMS Health, where she was the global director for core data assets.

She also brings pharma experience from Schering-Plough (now MSD) and GlaxoSmithKline, where she worked for 13 years in sales, training and marketing roles.

M3 Europe Grant IrwinMeanwhile, Irwin joins M3 Europe from Patient Connect, where he spent three years as general manager of patient compliance services Europe.

Prior to this he served at companies including Agnitio and IMS Health, in the process working with al of the top 20 life science companies on both a regional and global basis.

Tim Ringrose, CEO of M3 Europe, said: "I am pleased and excited to welcome both Grant and Helen to M3 Europe. Their arrival will provide immediate benefits for our clients and M3 as whole as a result of their extensive expertise and knowledge."

24th December 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics